Official UK procurement notice
Leuprorelin (Prostap®) · UK public procurement notice
Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) (NHS & healthcare)
What is being bought
Published requirement descriptionSupply of Leuprorelin (Prostap®) to NHS Scotland.
CPV: Pharmaceutical products
How this framework works
From the published notice- Bids received
- 1 bids received · 1 suppliers appointed
The lotProcurement structure
single lot · no lot value publishedLot #1Supply of Leuprorelin (Prostap®) to NHS ScotlandAwarded
Supply of Leuprorelin (Prostap®) to NHS Scotland. The Authority has awarded this framework as a single supplier framework per line to one (1) Framework Participant. II.2.11) Information about option.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 5 Nov 2025, 12:48 GMT
- Last source update
- 2 Dec 2025, 08:51 GMT
- Authority reference
NP90225b- FTS notice number
2025/S 000-078711- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-05dae3Find a Tender
- Why no open competition
The works, supplies or services can be provided only by a particular economic operator due to absence of competition for technical reasons
- Published justification
The patent for Leuprorelin (Prostap®) expired in June 2023, there is no known competition that has entered the UK market place and there is none anticipated for initial duration of the framework agreement.
Publisher note: The total value in Sections II.1.7 and V.2.4 refers to the fourteen (14) months initial period with the option to extend by up to a total period of thirty four (34) months. (SC Ref:817181)
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast2 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.
Contracts
All 2 of these contracts carry the same published figure, £2,625,907, the framework's maximum for the whole notice, not each contract's own value. They are not eleven separate sums.
Contract 071242-2025-NP90225b-1
- Signed
- 5 Nov 2025
- Value
- ceiling above
- Status
- active
Contract 078711-2025-NP90225b-1
- Signed
- 5 Nov 2025
- Value
- ceiling above
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids · 1 electronic · 1 from abroad | 0 | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Edinburgh Sheriff CourtReview body
Framework contractors & participating bidders
1 commercial party on the notice- Takeda UK LimitedFramework contractor
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.